当前位置:
X-MOL 学术
›
Nat. Rev. Cardiol.
›
论文详情
Our official English website, www.x-mol.net, welcomes your
feedback! (Note: you will need to create a separate account there.)
Anticoagulation therapy: Bivalirudin not superior to heparin in PCI
Nature Reviews Cardiology ( IF 41.7 ) Pub Date : 2017-09-14 , DOI: 10.1038/nrcardio.2017.142 Gregory B. Lim
Nature Reviews Cardiology ( IF 41.7 ) Pub Date : 2017-09-14 , DOI: 10.1038/nrcardio.2017.142 Gregory B. Lim
Anticoagulation therapy: Bivalirudin not superior to heparin in PCI
中文翻译:
抗凝疗法:比伐卢定在PCI中不优于肝素
抗凝疗法:比伐卢定在PCI中不优于肝素
更新日期:2017-09-14
Nature Reviews Cardiology, Published online: 14 September 2017; doi:10.1038/nrcardio.2017.142
中文翻译:
抗凝疗法:比伐卢定在PCI中不优于肝素
抗凝疗法:比伐卢定在PCI中不优于肝素
《自然评论心脏病学》,在线发布:2017年9月14日;doi:10.1038 / nrcardio.2017.142